125
Participants
Start Date
September 25, 2017
Primary Completion Date
February 5, 2019
Study Completion Date
October 4, 2022
Teriflunomide 14 MG Oral Tablet [Aubagio]
1 tablet once a day
Placebo Oral Tablet
1 tablet once a day
Inselspital Bern, Bern
CHU de Toulouse, Toulouse
CHU de Bordeaux, Bordeaux
CHRU de Montpellier, Montpellier
CHU de Rennes, Rennes
Ege University Medical Faculty, Izmir
CHRU de Lille, Lille
CHU de Strasbourg, Strasbourg
Hospices Civils de Lyon, Lyon
APHP - Hôpital La Pitié Salpêtrière, Paris
CHU de Caen, Caen
CHU de Clermont-Ferrand, Clermont-Ferrand
CHU de Grenoble, Grenoble
CHU de Nantes, Nantes
CHU de Nîmes, Nîmes
CHU de Rouen, Rouen
Hacettepe University, Ankara
Mustafa Kemal University, Antakya
Uludag University School of Medicine, Bursa
Istanbul University, Istanbul
Kocaeli University School of Medicine, Kocaeli
Ondokuz Mayis University, Faculty of Medicine, Samsun
CHU de Nice, Nice
Genzyme, a Sanofi Company
INDUSTRY
Centre Hospitalier Universitaire de Nice
OTHER